Variant position: 35 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 427 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Mouse DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Rat DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Pig DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Bovine DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Chicken DFDRNVPRICGVCGDRATGF HFNAMTCEGCKGFFRRSMKRK
Xenopus laevis EFDKNVPRICGVCGDKATGF HFNAMTCEGCKGFFRRSMKRK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 427 Vitamin D3 receptor
21 – 96 Nuclear receptor
24 – 44 NR C4-type
33 – 35
A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Yagi H.; Ozono K.; Miyake H.; Nagashima K.; Kuroume T.; Pike J.W.;
J. Clin. Endocrinol. Metab. 76:509-512(1993)
Cited for: VARIANT VDDR2A GLN-35;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.